97 related articles for article (PubMed ID: 8631361)
1. Oxidative inactivation of human 5-lipoxygenase in phosphatidylcholine vesicles.
De Carolis E; Denis D; Riendeau D
Eur J Biochem; 1996 Jan; 235(1-2):416-23. PubMed ID: 8631361
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the mechanism of non-turnover-dependent inactivation of purified human 5-lipoxygenase. Inactivation by H2O2 and inhibition by metal ions.
Percival MD; Denis D; Riendeau D; Gresser MJ
Eur J Biochem; 1992 Nov; 210(1):109-17. PubMed ID: 1446663
[TBL] [Abstract][Full Text] [Related]
3. Kinetic studies on the inactivation of 5-lipoxygenase by 5(S)-hydroperoxyeicosatetraenoic acid.
Aharony D; Redkar-Brown DG; Hubbs SJ; Stein RL
Prostaglandins; 1987 Jan; 33(1):85-100. PubMed ID: 3108961
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides.
Riendeau D; Falgueyret JP; Nathaniel DJ; Rokach J; Ueda N; Yamamoto S
Biochem Pharmacol; 1989 Jul; 38(14):2313-21. PubMed ID: 2502118
[TBL] [Abstract][Full Text] [Related]
5. Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations.
Skorey KI; Gresser MJ
Biochemistry; 1998 Jun; 37(22):8027-34. PubMed ID: 9609696
[TBL] [Abstract][Full Text] [Related]
6. Interfacial catalysis and production of a high ratio of leukotriene A4 to 5-HPETE by 5-lipoxygenase in a coupled assay with phospholipase A2.
Riendeau D; Falgueyret JP; Meisner D; Sherman MM; Laliberté F; Street IP
J Lipid Mediat; 1993; 6(1-3):23-30. PubMed ID: 8395245
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the activity of purified recombinant human 5-lipoxygenase in the absence and presence of leukocyte factors.
Denis D; Falgueyret JP; Riendeau D; Abramovitz M
J Biol Chem; 1991 Mar; 266(8):5072-9. PubMed ID: 1848236
[TBL] [Abstract][Full Text] [Related]
8. Suicide inactivation of porcine leukocyte 12-lipoxygenase associated with its incorporation of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid derivative.
Kishimoto K; Nakamura M; Suzuki H; Yoshimoto T; Yamamoto S; Takao T; Shimonishi Y; Tanabe T
Biochim Biophys Acta; 1996 Mar; 1300(1):56-62. PubMed ID: 8608163
[TBL] [Abstract][Full Text] [Related]
9. N-(4-chlorophenyl)-N-hydroxy-N'-(3-chlorophenyl)urea, a general reducing agent for 5-, 12-, and 15-lipoxygenases and a substrate for their pseudoperoxidase activities.
Falgueyret JP; Desmarais S; Roy PJ; Riendeau D
Biochem Cell Biol; 1992; 70(3-4):228-36. PubMed ID: 1515123
[TBL] [Abstract][Full Text] [Related]
10. Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes.
Lepley RA; Fitzpatrick FA
J Biol Chem; 1994 Jan; 269(4):2627-31. PubMed ID: 8300592
[TBL] [Abstract][Full Text] [Related]
11. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C.
Bakker HM; Tans G; Janssen-Claessen T; Thomassen MC; Hemker HC; Griffin JH; Rosing J
Eur J Biochem; 1992 Aug; 208(1):171-8. PubMed ID: 1387359
[TBL] [Abstract][Full Text] [Related]
12. Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities.
Rouzer CA; Matsumoto T; Samuelsson B
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):857-61. PubMed ID: 3006030
[TBL] [Abstract][Full Text] [Related]
13. Human 5-lipoxygenase associates with phosphatidylcholine liposomes and modulates LTA4 synthetase activity.
Noguchi M; Miyano M; Matsumoto T; Noma M
Biochim Biophys Acta; 1994 Dec; 1215(3):300-6. PubMed ID: 7811715
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of porcine leukocyte 12-lipoxygenase by the isoform-specific inhibitor 4-(2-oxapentadeca-4-yne)phenylpropanoic acid.
Richards KM; Moody JS; Marnett LJ
Biochemistry; 1999 Dec; 38(50):16529-38. PubMed ID: 10600114
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the human leukocyte 5-lipoxygenase: stimulation by micromolar Ca2+ levels and phosphatidylcholine vesicles.
Puustinen T; Scheffer MM; Samuelsson B
Biochim Biophys Acta; 1988 Jun; 960(3):261-7. PubMed ID: 3382674
[TBL] [Abstract][Full Text] [Related]
16. Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets.
Chang WC; Nakao J; Orimo H; Murota S
Biochem J; 1982 Mar; 202(3):771-6. PubMed ID: 6807297
[TBL] [Abstract][Full Text] [Related]
17. Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid.
Shimizu T; Rådmark O; Samuelsson B
Proc Natl Acad Sci U S A; 1984 Feb; 81(3):689-93. PubMed ID: 6322165
[TBL] [Abstract][Full Text] [Related]
18. Irreversible inhibition of soybean lipoxygenase-1 by hydroperoxy acids as substrates.
Kim MR; Sok DE
Arch Biochem Biophys; 1991 Jul; 288(1):270-5. PubMed ID: 1910308
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene A synthase activity of purified mouse skin arachidonate 8-lipoxygenase expressed in Escherichia coli.
Qiao N; Takahashi Y; Takamatsu H; Yoshimoto T
Biochim Biophys Acta; 1999 Apr; 1438(1):131-9. PubMed ID: 10216287
[TBL] [Abstract][Full Text] [Related]
20. Effects of the 5-lipoxygenase activating protein inhibitor MK886 on voltage-gated and Ca2+-activated K+ currents in rat arterial myocytes.
Smirnov SV; Knock GA; Aaronson PI
Br J Pharmacol; 1998 Jun; 124(3):572-8. PubMed ID: 9647483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
